Denver, CO – Revelstoke Capital Partners, LLC (“Revelstoke”) is pleased to announce three promotions and two hires to its investment team.
Andrew Welch and Arion Robbins were promoted to Principal. Mr. Welch joined Revelstoke in early 2014 and serves on the board of directors of Revelstoke portfolio companies Upstream Rehabilitation, Encore Rehabilitation and Transport Investments. Mr. Robbins joined Revelstoke in 2013 and serves on the board of directors of Revelstoke portfolio companies Schryver Medical, Career Step, Crossroads Treatment Centers and Fast Pace Urgent Care.
Jonathan Miller was promoted to Senior Associate. Mr. Miller joined Revelstoke in 2013 from the Royal Bank of Canada’s investment banking group and is involved in evaluating opportunities and executing transactions at Revelstoke, including the firm’s investments in Upstream Rehabilitation, Schryver Medical, Career Step, Crossroads Treatment Centers, Fast Pace Urgent Care and Accelecare Wound Centers.
Michael Constantinides and Alan Fredian recently joined the firm as Associates. Mr. Constantinides was previously an analyst at Cain Brothers & Co. in New York, where he focused on mergers and acquisitions in the healthcare services industry. Mr. Constantinides holds a B.B.A. in Finance from the McCombs School of Business at the University of Texas at Austin. Mr. Fredian was previously an analyst in the Healthcare Group of Houlihan Lokey, Inc. in Chicago. Mr. Fredian holds a B.S. in Accounting and a B.S. in Finance from the University of Illinois at Urbana-Champaign.
“We are pleased to promote and recognize these individuals who have made significant contributions to the success of our firm. We welcome Michael and Alan to the team – they have excellent experience from leading investment banks in the healthcare industry, institutions with which we have strong relationships and that we have worked with completing platform acquisitions,” said Simon Bachleda, Co-Founder and Managing Partner at Revelstoke.
Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading healthcare and business services companies. Revelstoke strives to partner with management teams to execute on a disciplined organic and acquisition strategy to build exceptional companies. Since the firm’s inception in mid-2013, Revelstoke has raised in excess of $700 million in equity commitments across its various investing entities and has completed 23 acquisitions totaling over $1.2 billion in enterprise value.
Simon Bachleda, Managing Partner: 303-953-3098
Dale Meyer, Managing Partner: 303-953-3094